glp-1 discontinuation rates Most adults with overweight or obesity discontinue therapy within 2 years High Discontinuation Rates of GLP-1

doi: 10.1111/hepr.12837

Research has yielded conflicting results, especially with regard to ulcerative colitis

As a result, people are eating 700 calories less than they normally would

The robust presence of innate immune elements at the leading edges led some to conclude that in these chronic active MS lesions, there is a switch with the innate rather than the adaptive immune system taking over to propagate the pathology (Weiner, 2008)

Purpose-built for physicians Encouraging signal: GLP-1s may help reduce breast cancer recurrence, improve survival Key takeaways: GLP-1 use may improve outcomes among women with breast cancer who also have obesity or diabetes

Frequently Asked Questions Not sure if it's right for you